Comments
Loading...

Monopar Therapeutics

MNPRNASDAQ
Logo brought to you by Benzinga Data
$16.88
1.157.31%
At close: -
$16.16
-0.72-4.27%
After Hours: 7:47 PM EDT
Q3 2024 earnings were released today before the market open

Monopar Therapeutics (NASDAQ:MNPR) Stock Quotes, Forecast and News Summary

Monopar Therapeutics Stock (NASDAQ: MNPR) stock price, news, charts, stock research, profile.

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trends and Forecast
0
0
0
0
May
0
0
0
0
Aug
0
0
0
0
Oct
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
4.0
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell
Open$16.40
Close$16.88
Volume / Avg.158.15K / 1.23M
Day Range$15.50 - $17.79
52 Wk Range1.37 - 38.50
Market Cap$56.89M
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
58
Short Interest
10.22%
Days to Cover1

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
MNPR
FBIO

FAQ

Q

How do I buy Monopar Therapeutics (MNPR) stock?

A

You can purchase shares of Monopar Therapeutics (NASDAQ:MNPR) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Monopar Therapeutics (MNPR) competitors?

Q

What is the forecast, or price target, for Monopar Therapeutics (MNPR) stock?

A

Monopar Therapeutics has a consensus price target of $18.60.

Q

What is the current price for Monopar Therapeutics (MNPR)?

A

The stock price for Monopar Therapeutics (NASDAQ: MNPR) is $16.16 last updated November 8, 2024 at 7:47 PM EST.

Q

Does Monopar Therapeutics (MNPR) pay a dividend?

A

There are no upcoming dividends for Monopar Therapeutics.

Q

When is Monopar Therapeutics (NASDAQ:MNPR) reporting earnings?

A

Monopar Therapeutics’s Q3 earnings are confirmed for Friday, November 8, 2024.

Q

Is Monopar Therapeutics (MNPR) going to split?

A

There is no upcoming split for Monopar Therapeutics.

Q

What sector and industry does Monopar Therapeutics (MNPR) operate in?

A

Monopar Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch